A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.

Branched DNA (bDNA) is a signal amplification technology used in clinical and research laboratories to quantitatively detect nucleic acids. An overnight incubation is a significant drawback of highly sensitive bDNA assays. The VERSANT® HIV-1 RNA 3.0 Assay (bDNA) ("Versant Assay") currently...

Full description

Bibliographic Details
Main Authors: Mark A Baumeister, Nan Zhang, Hilda Beas, Jesse R Brooks, Jesse A Canchola, Carlo Cosenza, Felix Kleshik, Vinod Rampersad, Johan Surtihadi, Thomas R Battersby
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3314011?pdf=render
id doaj-e98471abe7ae4774a16064fb57f818c5
record_format Article
spelling doaj-e98471abe7ae4774a16064fb57f818c52020-11-25T02:28:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3329510.1371/journal.pone.0033295A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.Mark A BaumeisterNan ZhangHilda BeasJesse R BrooksJesse A CancholaCarlo CosenzaFelix KleshikVinod RampersadJohan SurtihadiThomas R BattersbyBranched DNA (bDNA) is a signal amplification technology used in clinical and research laboratories to quantitatively detect nucleic acids. An overnight incubation is a significant drawback of highly sensitive bDNA assays. The VERSANT® HIV-1 RNA 3.0 Assay (bDNA) ("Versant Assay") currently used in clinical laboratories was modified to allow shorter target incubation, enabling the viral load assay to be run in a single day. To dramatically reduce the target incubation from 16-18 h to 2.5 h, composition of only the "Lysis Diluent" solution was modified. Nucleic acid probes in the assay were unchanged. Performance of the modified assay (assay in development; not commercially available) was evaluated and compared to the Versant Assay. Dilution series replicates (>950 results) were used to demonstrate that analytical sensitivity, linearity, accuracy, and precision for the shorter modified assay are comparable to the Versant Assay. HIV RNA-positive clinical specimens (n = 135) showed no significant difference in quantification between the modified assay and the Versant Assay. Equivalent relative quantification of samples of eight genotypes was demonstrated for the two assays. Elevated levels of several potentially interfering endogenous substances had no effect on quantification or specificity of the modified assay. The modified assay with drastically improved turnaround time demonstrates the viability of signal-amplifying technology, such as bDNA, as an alternative to the PCR-based assays dominating viral load monitoring in clinical laboratories. Highly sensitive bDNA assays with a single day turnaround may be ideal for laboratories with especially stringent cost, contamination, or reliability requirements.http://europepmc.org/articles/PMC3314011?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Mark A Baumeister
Nan Zhang
Hilda Beas
Jesse R Brooks
Jesse A Canchola
Carlo Cosenza
Felix Kleshik
Vinod Rampersad
Johan Surtihadi
Thomas R Battersby
spellingShingle Mark A Baumeister
Nan Zhang
Hilda Beas
Jesse R Brooks
Jesse A Canchola
Carlo Cosenza
Felix Kleshik
Vinod Rampersad
Johan Surtihadi
Thomas R Battersby
A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.
PLoS ONE
author_facet Mark A Baumeister
Nan Zhang
Hilda Beas
Jesse R Brooks
Jesse A Canchola
Carlo Cosenza
Felix Kleshik
Vinod Rampersad
Johan Surtihadi
Thomas R Battersby
author_sort Mark A Baumeister
title A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.
title_short A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.
title_full A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.
title_fullStr A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.
title_full_unstemmed A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.
title_sort sensitive branched dna hiv-1 signal amplification viral load assay with single day turnaround.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Branched DNA (bDNA) is a signal amplification technology used in clinical and research laboratories to quantitatively detect nucleic acids. An overnight incubation is a significant drawback of highly sensitive bDNA assays. The VERSANT® HIV-1 RNA 3.0 Assay (bDNA) ("Versant Assay") currently used in clinical laboratories was modified to allow shorter target incubation, enabling the viral load assay to be run in a single day. To dramatically reduce the target incubation from 16-18 h to 2.5 h, composition of only the "Lysis Diluent" solution was modified. Nucleic acid probes in the assay were unchanged. Performance of the modified assay (assay in development; not commercially available) was evaluated and compared to the Versant Assay. Dilution series replicates (>950 results) were used to demonstrate that analytical sensitivity, linearity, accuracy, and precision for the shorter modified assay are comparable to the Versant Assay. HIV RNA-positive clinical specimens (n = 135) showed no significant difference in quantification between the modified assay and the Versant Assay. Equivalent relative quantification of samples of eight genotypes was demonstrated for the two assays. Elevated levels of several potentially interfering endogenous substances had no effect on quantification or specificity of the modified assay. The modified assay with drastically improved turnaround time demonstrates the viability of signal-amplifying technology, such as bDNA, as an alternative to the PCR-based assays dominating viral load monitoring in clinical laboratories. Highly sensitive bDNA assays with a single day turnaround may be ideal for laboratories with especially stringent cost, contamination, or reliability requirements.
url http://europepmc.org/articles/PMC3314011?pdf=render
work_keys_str_mv AT markabaumeister asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT nanzhang asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT hildabeas asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT jesserbrooks asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT jesseacanchola asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT carlocosenza asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT felixkleshik asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT vinodrampersad asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT johansurtihadi asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT thomasrbattersby asensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT markabaumeister sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT nanzhang sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT hildabeas sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT jesserbrooks sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT jesseacanchola sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT carlocosenza sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT felixkleshik sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT vinodrampersad sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT johansurtihadi sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
AT thomasrbattersby sensitivebrancheddnahiv1signalamplificationviralloadassaywithsingledayturnaround
_version_ 1724836962659991552